Home › Products › Hematology › Desferal 500mg Injection
Desferal 500mg Injection
Salt Composition: DEFEROXAMINE
- Manufacturer: NOVARTIS INDIA LTD
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 500MG
- Prescription Required
- Storage: Stored at controlled room temperature, between 20°C to 25°C (68°F to 77°F). Keep away from moisture, heat, and light. It should not be frozen. Keep away from children and pets.
₹297.00₹297.12
Inclusive of all taxes
Product Introduction
Desferal 500mg Injection contains deferoxamine as its active component. This medication is used to treat iron overload in the body and belongs to a class of drugs called iron-chelating agents.
Iron overload occurs in conditions including thalassemia, hemochromatosis, sickle cell disease, myelodysplastic syndromes, chronic transfusions, and iron poisoning. Thalassemia is an inherited blood disorder that causes abnormal hemoglobin production and anemia. Hemochromatosis is a hereditary condition characterised by excessive iron absorption, leading to iron accumulation in organs. Sickle cell disease is a genetic disorder affecting red blood cell shape, causing pain and organ damage. Myelodysplastic syndromes are blood disorders affecting the bone marrow and resulting in abnormal blood cell production. Chronic transfusions, required for severe anemia or blood disorders, can lead to iron overload. Iron poisoning occurs when toxic amounts of iron are ingested; Desferal 500mg Injection works to eliminate excess iron from the body.
In conditions such as thalassemia, hemochromatosis, or chronic transfusions, excessive iron accumulates in organs and tissues, potentially causing organ damage. By managing iron overload, Desferal 500mg Injection may improve quality of life for patients with conditions causing iron accumulation. It may help reduce symptoms including fatigue, joint pain, and other complications associated with iron overload. Proper management of iron overload with this medication may help prolong life expectancy in individuals with iron-related disorders by preventing severe organ damage and complications. Iron overload can lead to serious complications such as liver disease, heart problems, and endocrine disorders. By reducing excess iron levels, the medication helps lower the risk of such complications.
Patients with known allergy to deferoxamine or any component of Desferal 500mg Injection should not use this medication. Allergic reactions can range from mild skin rashes to severe anaphylactic reactions, which can be life-threatening. The medication is primarily excreted by the kidneys. Patients with significant kidney impairment may not be suitable candidates for therapy or may require dosage adjustments and close monitoring. Hearing and vision disturbances have been associated with this medication in some patients. Individuals with pre-existing hearing or vision problems should exercise caution and may require more frequent monitoring. Desferal 500mg Injection is not suitable for treating iron deficiency anemia and can exacerbate iron deficiency; it should not be used in individuals with low iron levels. While this medication can be used in paediatric patients, careful monitoring and appropriate dosage adjustments based on weight and individual needs are essential.
Uses
Desferal 500mg Injection is used in the treatment of the following: Thalassemia Hemochromatosis Sickle cell disease Myelodysplastic syndromes Chronic transfusions Iron poisoning
How it works
The mechanism of action of Desferal 500mg Injection involves chelation, a process by which the drug binds to excess iron in the body. It forms stable complexes with free iron ions, particularly the trivalent iron, creating water-soluble compounds. These iron-deferoxamine complexes are then excreted primarily through the urine, effectively removing the excess iron from the bloodstream and tissues. By reducing iron levels, this medication helps to prevent iron-related oxidative damage to organs and tissues, mitigating the risk of organ dysfunction and other complications associated with iron overload conditions such as thalassemia, hemochromatosis, and chronic transfusions.
How to Use
Healthcare professionals typically administer Desferal 500mg Injection in a hospital or clinical setting. The injection may be given as an injection, depending on the treatment condition and the healthcare provider's instructions. Before administration, the healthcare professional will assess the patient's patient's medical history, current health status, and any known allergies or sensitivities.
Side Effects
Desferal 500mg Injection causes some side effects like all medications, although not everyone will experience them. Serious: Tightness of chest with wheezing or coughing and difficulty in breathing Allergic reactions (facial and throat swelling, feeling faint, rash) Decreased urine output Seizures Infections (fever accompanied by stomach pain and shortness of breath) Common: Pain, swelling, redness, and itching at the injection site Headache Reddish-brown color of urine Nausea Fever, feeling sick Slow growth in children under age three
Expert Tips
It is essential to inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are taking to avoid potential drug interactions or contraindications. Regular monitoring of iron levels, kidney function, and blood counts is crucial during treatment to ensure appropriate dosing and to detect any adverse effects promptly. If you experience any signs of allergic reactions, visual or hearing changes, difficulty breathing, or severe skin reactions, seek immediate medical attention. Take caution while driving or operating machinery, especially if you experience dizziness or headaches. Abrupt discontinuation of medication may lead to a rebound increase in iron levels, potentially exacerbating iron overload. Pregnant or breastfeeding individuals should discuss the potential risks with their healthcare provider before initiating treatment. Finally, adherence to the prescribed treatment plan and close communication with your healthcare team will help optimise the safety and effectiveness of Desferal 500mg Injection therapy.
References
- KD Tripathi, Essentials of Medical Pharmacology, Haematinics and Erythropoietin, 7th edition, 2013, 606.
- Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Environmental toxicology: Carcinogenesis and heavy metals, 12th edition, 2011,1875.
- Novartis Pharmaceuticals UK Ltd, Electronic medicines compendium (EMC), [Revised on June 2020] [ Accessed on 28th July 2023], https://www.medicines.org.uk/emc/files/pil.3813.pdf
- Novartis, US Food and Drug Administration, [ Revised on Nov 2007] [Accessed on 28th July 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/016267s044lbl.pdf
Safety Advice
Pregnancy: Consult your doctor Desferal 500mg Injection use during pregnancy with caution and only used after consulting a healthcare provider.
Lungs: safe Desferal 500mg Injection is generally safe to use in individuals with normal lung function. However, caution should be exercised in patients with pre-existing lung conditions or compromised respiratory function.
Breastfeeding: Consult your doctor The safety of Desferal 500mg Injection in breastfeeding has not been established, and there is a concern about the potential adverse effects it may have on the nursing baby.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.